These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1893436)
21. [Microalbuminuria in insulin-dependent diabetics: the prevention of diabetic nephropathy]. Durruty P; Krause P; Pérez F; García de los Ríos M; López G; Durruty G Rev Med Chil; 1990 Dec; 118(12):1319-25. PubMed ID: 2152662 [TBL] [Abstract][Full Text] [Related]
22. Recent advance in the treatment of diabetic nephropathy: angiotensin I converting enzyme (ACE) inhibitors. Marre M J Diabet Complications; 1991; 5(2-3):91. PubMed ID: 1770064 [No Abstract] [Full Text] [Related]
23. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat. Ding SS; Qiu C; Hess P; Xi JF; Zheng N; Clozel M J Cardiovasc Pharmacol; 2003 Jul; 42(1):48-54. PubMed ID: 12827026 [TBL] [Abstract][Full Text] [Related]
24. Renal protective effect of enalapril in diabetic nephropathy. Björck S; Mulec H; Johnsen SA; Nordén G; Aurell M BMJ; 1992 Feb; 304(6823):339-43. PubMed ID: 1540729 [TBL] [Abstract][Full Text] [Related]
25. [Renoprotective effect of monopril in patients with diabetes mellitus in the preclinical stage of diabetic nephropathy]. Lapchyns'ka II; Zhurylo TIe; Seliuk MM; Hromova AIe Lik Sprava; 2002; (5-6):91-3. PubMed ID: 12442535 [TBL] [Abstract][Full Text] [Related]
26. Microalbuminuria and ACE inhibition in non-hypertensive diabetics. Marre M J Diabet Complications; 1990; 4(2):84-5. PubMed ID: 2145309 [No Abstract] [Full Text] [Related]
27. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Björck S; Mulec H; Johnsen SA; Nyberg G; Aurell M BMJ; 1990 Apr; 300(6729):904-7. PubMed ID: 2337713 [TBL] [Abstract][Full Text] [Related]
28. [Glomerular hyperfiltration and diabetic nephropathy]. Prkacin I; Bulum T Acta Med Croatica; 2012 Oct; 66 Suppl 2():37-41. PubMed ID: 23513414 [TBL] [Abstract][Full Text] [Related]
29. Combining antihypertensive agents in early diabetic nephropathy. Christensen CK; Pedersen MM; Mogensen CE J Diabet Complications; 1990; 4(2):88-90. PubMed ID: 2145311 [No Abstract] [Full Text] [Related]
30. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat: are these effects specific for enalapril? Baba T; Sawicki PT Diabetologia; 1989 Nov; 32(11):829. PubMed ID: 2556309 [No Abstract] [Full Text] [Related]
31. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Ravid M; Neumann L; Lishner M Kidney Int; 1995 Mar; 47(3):907-10. PubMed ID: 7752591 [TBL] [Abstract][Full Text] [Related]
32. Prevention of diabetic nephropathy with enalapril. Marre M; Passa P; Chatellier G; Menard J BMJ; 1989 Feb; 298(6671):459-60. PubMed ID: 2539216 [No Abstract] [Full Text] [Related]
33. Prevention of diabetic nephropathy with enalapril. Pickering S; Sampson M; Foyle W; Drury P BMJ; 1988 Dec; 297(6663):1610. PubMed ID: 2852041 [No Abstract] [Full Text] [Related]
34. Renal protective effect of enalapril in diabetic nephropathy. Sawicki PT; Berger M BMJ; 1992 Mar; 304(6830):841; author reply 841-2. PubMed ID: 1392723 [No Abstract] [Full Text] [Related]
35. The salt paradox and its possible implications in managing hypertensive diabetic patients. Vallon V; Blantz R; Thomson S Curr Hypertens Rep; 2005 Apr; 7(2):141-7. PubMed ID: 15748540 [TBL] [Abstract][Full Text] [Related]